Exelixis (EXEL) Net Margin (2010 - 2026)

Exelixis' (EXEL) quarterly Net Margin came in at 34.46% in Q2 2026, up 572.0% year-on-year from 5.13% in Q2 2025, and down 15.64% quarter-over-quarter from 40.85% in Q1 2026.

Exelixis (EXEL) Net Margin (2010 - 2026) Analysis & Trends

Exelixis' Net Margin history runs 17 years deep, the most recent figure standing at 34.46% for Q2 2026.

  • On a quarterly basis, Net Margin rose 572.0% year-over-year to 34.46% in Q2 2026; TTM through Apr 2026 was 35.08%, a 709.0% increase from a year earlier, with the FY2026 full-year figure at 33.73%, up 969.0% from the prior year.
  • Net Margin declined to 34.46% in Q2 2026 per EXEL's latest filing, from 40.85% in the prior quarter.
  • Across five years, Net Margin topped out at 40.85% in Q1 2026 and bottomed at 7.12% in Q4 2022.
  • The 5-year median for Net Margin is 19.26% (2022), against an average of 20.69%.
  • Biggest YoY gain for Net Margin was 2495 bps in 2023; the steepest drop was 1756 bps in 2023.
  • Year by year, Net Margin stood at 7.12% in 2022, then surged by 350 bps to 17.83% in 2023, then advanced by 23 bps to 21.87% in 2024, then surged by 48 bps to 32.38% in 2025, then advanced by 6 bps to 34.46% in 2026.
  • Per Business Quant, the three latest EXEL Net Margin figures stand at 34.46% (Q2 2026), 40.85% (Q1 2026), and 32.38% (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn 34.46%

Historic Data

Download Data
DateValue
Apr 3, 2026 34.46%
Jan 2, 2026 40.85%
Oct 3, 2025 32.38%
Jul 4, 2025 32.53%
Apr 4, 2025 28.74%
Jan 3, 2025 24.68%
Sep 27, 2024 21.87%
Jun 28, 2024 35.49%
Mar 29, 2024 8.78%
Dec 29, 2023 17.83%
Sep 29, 2023 0.22%
Jun 30, 2023 17.28%
Mar 31, 2023 9.79%
Dec 30, 2022 -7.12%
Sep 30, 2022 17.78%
Jul 1, 2022 16.85%
Apr 1, 2022 19.26%
Oct 1, 2021 11.63%
Jul 2, 2021 24.95%
Apr 2, 2021 0.59%